|
|
| FDA Recall, Rare GLP-1 Side Effects, and Rethinking Lung Cancer |
| From blood pressure drug recall and rare GLP-1 symptoms to an eye-opening column on nonsmoker lung cancer, here is your health news roundup this week. |
The FDA recently issued a nationwide blood pressure medication recall due to potential contamination. Patients should consult their doctor before stopping treatment. Meanwhile, researchers are tracking rare GLP-1 symptoms, including reports of detached fingernails and hair loss.
In online wellness trends, the “Wolverine” peptide is making rounds for its promise of rapid recovery. Experts explain what science actually says about BPC-157 for pain recovery and the risks of unproven peptide therapies.
Finally, in a special column feature, our Editor-in-Chief, Robin Hough, sits down with his longtime friend and psychologist, Gini Harrison, who has never smoked and is living with stage 4 lung cancer, which was first mistaken for a breastfeeding injury.
Their conversation challenges who we picture when we think of lung cancer and why that picture may be delaying diagnoses.
Which of these stories caught your eye this week? Let us know your thoughts emailing me. |
|
| Angela Chao, MA |
| Head of Global News |
|
|
|
|
|
|
|
|
|
|
|
|
| Until next time, |
 |
Take care of yourself, and we'll
see you again soon! |
|
|
|
|
|
View in browser
Did a friend send you this email? Subscribe here.
To see all newsletters, click here.
Privacy | Update Preferences or Unsubscribe
We may feature your messages to our inbox within our content. Please do not provide any personal identifiable information. Replies may be edited for length and clarity. For more, see our Privacy Policy.
Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional.
Every product we recommend has gone through either Healthline's or Optum Now's vetting processes. If you buy through links on this page, we may receive a small commission or other tangible benefit. Healthline has sole editorial control over this newsletter. Potential uses for the products listed here are not health claims made by the manufacturers. Healthline and Optum Now are owned by RVO Health.
We may feature your messages to our inbox within our content. Please do not provide any personal identifiable information. Replies may be edited for length and clarity. For more, see our Privacy Policy.
Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional.
Every product we recommend has gone through either Healthline’s or Optum Now’s vetting processes. If you buy through links on this page, we may receive a small commission or other tangible benefit. Healthline has sole editorial control over this newsletter. Potential uses for the products listed here are not health claims made by the manufacturers. Healthline and Optum Now are owned by RVO Health.
© 2026 RVO Health
1101 Red Ventures Drive
Fort Mill, SC 29707 |
|
